ROCKVILLE, Md., March 4, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that the Company will release financial results for the three and twelve months ended December 31, 2009, following the close of the market on Monday, March 29, 2010.
